1. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit;Agren;J. Immunol.,1997
2. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs—granulocyte-macrophage colony-stimulating factor and TNF-α synergize with IL-12 to enhance induction of cytotoxic T lymphocytes;Ahlers;J. Immunol.,1997
3. Dendritic cells and the control of immunity;Banchereau;Nature,1998
4. Improved methods for the generation of dendritic cells from non-proliferating progenitors in human blood;Bender;J. Immunol. Meth.,1996
5. The magnitude of the global problem of diarrhoeal disease: a 10 year update;Bern;Bull. WHO,1992